Eli Lilly announced on Monday a three-year extension of its cancer research collaboration with the Dana-Farber Cancer Institute. Since 2015, scientists from Lilly and Dana-Farber have been working together on pre-clinical and clinical studies, molecular analyses of patient samples and the design and conduct of clinical trials to help advance cancer care. 30 July 2018
Bristol-Myers Squibb (NYSE: BMY) has announced a research partnership with China's Tsinghua University, with the intent of carrying out research into fighting autoimmune diseases and cancer. 24 July 2018
Luye Pharma has been granted approval in China for Seroquel XR (quetiapine fumarate) for a new indication. The drug may now be marketed in the treatment of depression arising from bipolar disorder. 24 July 2018
Murdo Gordon, executive vice president and chief commercial officer at Bristol-Myers Squibb, will leave his post at the beginning of August 3. 23 July 2018
Privately-held Swiss drugmaker Ferring Pharmaceuticals says the US Food and Drug Administration has approved Zomacton (somatropin) for injection in four additional pediatric indications: 21 July 2018
The Prescription Medicines Code of Practice Authority (PMCPA) has called out four pharmaceutical firms for violating the UK industry’s code of practice. 19 July 2018
Germany’s leon-nanodrugs says that Takeda Pharmaceutical is undertaking a formal feasibility assessment of its ‘MicroJet Reactor’ nano-technology, with a view towards developing “an innovative formulation of one of their current pipeline products.” 17 July 2018
The US Food and Drug Administration has approved a supplemental New Drug Application (sNDA) for Xtandi (enzalutamide), from Japan’s Astellas Pharma and US pharma giant Pfizer, following FDA Priority Review designation based on results from the Phase III PROSPER trial. 14 July 2018
An investment vehicle of South Korea’s SK Group has inked a deal to acquire API developer AMPAC Fine Chemicals (AFC), providing SK with a strategic foothold in the key US contract development and manufacturing organization (CDMO) market. 12 July 2018
San Diegan gene therapy specialist Tocagen has closed a deal with a subsidiary of Beijing’s ApolloBio which grants the exclusive right to develop and commercialize the candidates Toca 511 & Toca FC in China. 11 July 2018
EUSA Pharma (today announced it has entered into a definitive agreement with France-headquartered SERB Pharmaceuticals for the sale of its critical care business. 11 July 2018
Indian drugmaker Glenmark Pharmaceuticals today announced the launch of Akynzeo, a fixed combination of netupitant 300mg and palonosetron 0.5mg, for the prevention of chemotherapy-induced nausea and vomiting (CINV), on to the Indian market. 10 July 2018
Takeda Pharmaceutical says it has received unconditional clearance from the US Federal Trade Commission (FTC) for the proposed $62 billion acquisition of Ireland-headquartered rare diseases specialist Shire that was announced on May 8, 2018. 10 July 2018
London-listed Hikma Pharmaceuticals has signed a licensing and distribution agreement with an affiliate of OTC healthcare firm Perrigo Company. 9 July 2018
Unconfirmed reports suggest Japan’s Takeda Pharmaceutical is preparing to auction its Osaka base, plus surrounding buildings, for up to 60 billion yen ($540 million). 6 July 2018
As a results of recent reports of yet another round of massive price hikes by drug manufacturers, Pharmaceutical Care Management Association (PCMA) president and chief executive Mark Merritt issued a statement saying: "News of recent price increases by drugmakers further confirms that the easiest way to lower costs would be for drug companies to lower their prices.” 6 July 2018
On June 19, 2018, Canada had passed a nationwide legalization of recreational cannabis usage, following Uruguay to become just the second nation to do so. 5 July 2018
Fiocruz, the Brazil-based Fundação Oswaldo Cruz, and the Economic Commission for Latin America and the Caribbean (ECLAC) have signed an international cooperation agreement aimed at compliance with the 2030 Agenda for Sustainable Development. 4 July 2018
A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget, due on October 30. 17 October 2024
The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza Vaccine) to include data from a new safety study involving pregnant women. 17 October 2024
Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma giant Novartis for a small molecule anti-tumor asset. 17 October 2024
Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), an innovative siderophore cephalosporin. 17 October 2024
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
India's Central Drugs Standard Control Organization (CDSCO) has provided a favorable recommendation for its novel antibiotic Miqnaf (nafithromycin) discovered and developed for the treatment of community-acquired bacterial pneumonia (CABP) in adults. 14 October 2024